Chemical Strategies to Enhance Antisense Strand Selection and Minimize Off-Target Effect-Mediated by siRNAs

Area of Science:

• Biochemistry
• Molecular Biology
• RNA Therapeutics

Background:

• Small interfering RNAs (siRNAs) are promising therapeutic agents for various diseases.
• Off-target effects from both sense and antisense strands limit siRNA efficacy.
• Argonaute 2 (AGO2) recognition and RNA-induced silencing complex (RISC) incorporation depend on the 5'-phosphate group.

Purpose of the Study:

• To describe a method for enhancing siRNA specificity and efficacy.
• To prevent off-target effects by blocking sense strand phosphorylation.
• To reduce unintended side effects of siRNA therapeutics.

Main Methods:

• Utilizing biotin, a naturally occurring compound, to block 5'-end phosphorylation.
• Applying this strategy to either the sense or antisense strand of siRNAs.
• Preventing the selection of siRNA strands by AGO2.

Main Results:

• Biotin effectively blocks 5'-end phosphorylation on siRNA strands.
• Blocking phosphorylation prevents siRNA strand incorporation into RISC.
• This strategy reduces potential off-target effects associated with siRNA use.

Conclusions:

• Blocking siRNA 5'-end phosphorylation with biotin is a practical approach.
• This method enhances siRNA specificity and therapeutic efficacy.
• The strategy offers a viable option to mitigate off-target effects in RNA therapeutics.